Funding for this research was provided by:
National Natural Science Foundation of China (81872430, 81872507)
Harbin Medical University (CN) Research and Innovation Project (YJSKYCX2019-55HYD)
Harbin Medical University Cancer Hospital (CN) Nn10 Project (Nn10py2017-01)
Harbin Medical University Cancer Hospital (CN) Key projects of Haiyan Fund (JJZD2017-01)
Received: 15 May 2020
Accepted: 6 October 2020
First Online: 12 October 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of the Tumor Hospital of Harbin Medical University (KY-2019-9) and written informed consent was provided by all participating patients before the start of this study.
: Not applicable.
: The authors declare that they have no competing interests.